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Abstract
Background—Few studies in Hispanic women have examined the relation between adult body 
size and risk of premenopausal breast cancer defined by hormone receptor status.
Methods—The Breast Cancer Health Disparities Study pooled interview and anthropometric 
data from two large U.S. population-based case-control studies. We examined associations of 
overall and abdominal adiposity with risk of estrogen receptor and progesterone receptor positive 
(ER+PR+) and negative (ER−PR−) breast cancer in Hispanic and non-Hispanic White (NHW) 
women, calculating odds ratios (OR) and 95% confidence intervals (CI).
Results—Among Hispanics, young-adult and current body mass index (BMI) were inversely 
associated with both ER+PR+ and ER−PR− breast cancer. For ER+PR+ disease, risk was 
substantially reduced among those with elevated BMI throughout adulthood (OR=0.35, 95% 
CI=0.19-0.62). Height and height-to-waist ratio were positively associated with ER−PR− breast 
cancer. After adjustment for current BMI, two-fold increased risks were seen for large waist and 
hip circumferences, regardless of tumor receptor status. Genetic ancestry appeared to modify some 
of the associations with overall and abdominal adiposity. Among NHWs, findings for overall 
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adiposity were similar to those for Hispanics, but there was no evidence of associations with 
abdominal adiposity.
Conclusions—Our findings for Hispanic women were generally similar to those reported for 
NHW women in other studies, with inverse associations for overall adiposity and positive 
associations for abdominal adiposity.
Impact—Abdominal obesity in young adulthood is an important risk factor for premenopausal 
breast cancer among Hispanic women.
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Introduction
Body mass index (BMI), a measure of overall adiposity, has been associated with decreased 
risk of premenopausal breast cancer (BC) (1-3), whereas waist circumference and waist-to-
hip ratio (WHR), two commonly used measures of abdominal or central adiposity, have 
been associated with increased risk (3-5). These findings are based on studies conducted in 
primarily non-Hispanic white (NHW) women. Only a few studies have reported on body 
size associations in premenopausal U.S. Hispanic women (6-10), and the findings are not 
consistent. Therefore, it is unclear whether the effects of overall and abdominal obesity on 
premenopausal BC risk in Hispanics are different from those in NHWs (11). Given the 
higher prevalence of overweight and obesity in Hispanics than NHWs (12), further 
investigation of the relation between body size and breast cancer risk in Hispanics is 
warranted.
In this report, we analyzed data for Hispanic and NHW women from two large population-
based case-control studies that were harmonized and pooled for the Breast Cancer Health 
Disparities Study (13). We assessed associations of overall and abdominal adiposity with 
risk of premenopausal BC defined by estrogen receptor (ER) and progesterone receptor (PR) 
status, which are important in characterizing risk profiles for hormone-related exposures 
such as body size (14). We also examined whether genetic ancestry among Hispanic women 
modified the body size associations, given our previous finding that overall and abdominal 
obesity are more common in Hispanic women with higher Indigenous American (IA) 
ancestry (15).
Materials and Methods
The Breast Cancer Health Disparities Study was approved by the institutional review board 
at each institution. Written informed consent was provided by all study participants.
San Francisco Bay Area Breast Cancer Study (SFBCS)
The SFBCS was conducted in Hispanic, African American and NHW women from the San 
Francisco Bay Area (16, 17). The Greater Bay Area Cancer Registry identified 17,537 cases 
aged 35-79 years with a first primary invasive BC diagnosed between April 1995 and April 
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2002. Controls were identified through random-digit dialing and were frequency matched to 
cases on race/ethnicity and the expected 5-year age distribution of cases. Self-reported race/
ethnicity and eligibility for several studies were assessed by a telephone screening interview, 
with participation rates of 89% among 15,573 cases contacted (alive, valid address, no 
physician refusal) and 92% among 3,547 controls contacted. For the SFBCS, women 
eligible for an in-person interview included all Hispanic cases diagnosed from 1995-2002, 
all African American cases diagnosed from 1995-1999, and a sample of NHW cases 
diagnosed from 1995-1999. Given the large number of diagnoses in NHW women, they 
were randomly sampled at 10%. Interview data were obtained for 1,715 cases, including 
1,119 (89%) Hispanics and 596 (86%) NHWs, and 2,108 controls, including 1,462 (88%) 
Hispanics and 646 (83%) NHWs. Median time between diagnosis and interview was 15.4 
months. The pooled analysis included Hispanics and NHWs only; body size associations for 
African Americans were reported elsewhere (9).
4-Corners Breast Cancer Study (4-CBCS)
The 4-CBCS included NHW, Hispanic, and Native American (NA) women from non-
reservation areas in Arizona, Colorado, New Mexico, and Utah (8). The state-wide cancer 
registries identified 5,256 cases aged 25-79 years with in situ or invasive BC diagnosed 
between October 1999 and May 2004; controls were selected from the populations living in 
the four states and were frequency matched to cases on race/ethnicity and expected 5-year 
age distribution. A total of 3,761 cases were contacted and 2,556 completed the in-person 
interview, including 873 Hispanics/NAs (63%) and 1,683 NHWs (71%). Of 6,152 controls 
contacted, 2,605 completed the interview, including 936 (36%) Hispanics/NAs and 1,669 
(47%) NHWs. The number of NAs (55 cases, 73 controls) was too small for separate 
analysis and they were combined with Hispanics. Cases were restricted to those with a first 
primary invasive breast cancer (662 Hispanics/NAs, 1,246 NHWs). Median time between 
diagnosis and interview was 17.8 months.
Data Collection
The two studies used similar structured questionnaires in English or Spanish to collect 
information on body size and other BC risk factors up to the reference year (defined as the 
calendar year prior to diagnosis for cases or selection into the study for controls). Trained 
professional bilingual interviewers administered the questionnaires in English or Spanish 
and also measured standing height (with shoes removed) and weight (with light clothing) at 
the time of interview, using a portable stadiometer and scale, respectively. Waist and hip 
circumferences were measured using a linen tape (in SFBCS) or a flexible tape (in 4-CBCS). 
In SFBCS, height was measured to the nearest millimeter, weight to the nearest 0.20 
kilogram, and waist and hip circumferences to the nearest millimeter. For each, three 
measurements were taken (except for two measurements of weight) and averaged (9). In 4-
CBCS, height was measured to the nearest 0.25 inch (in), weight to the nearest 0.50 pound 
(lb), and waist and hip circumferences to the nearest 0.50 in. For each, two measurements 
were taken (if they differed by >0.5 in for height, >1.0 in for waist or hip circumferences, or 
>1.0 lb for weight, a third measurement was taken) and averaged (8). Information on 
estrogen receptor (ER) and progesterone receptor (PR) status was obtained from the 
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respective cancer registries and was available for most premenopausal cases (84% in 
SFBCS, 79% in 4-CBCS).
Study Variables
Data from the two studies were harmonized according to common definitions (13). Women 
were classified as premenopausal if they reported having menstrual periods during the 
reference year. Based on current language usage, a three-level acculturation index was 
created for Hispanics (low: Spanish speaking only; moderate: speaking more Spanish than 
English or Spanish and English equally; high: speaking more English than Spanish or 
English only). Current BMI was calculated as weight (in kg) divided by height (in meter) 
squared, based on measured height at interview and self-reported weight in the reference 
year. Self-reported weight before diagnosis was used since weight measured at interview 
may have been affected by disease- or treatment-related weight gain or loss. For study 
participants who declined the height measurement, self-reported height was used (3% of 
cases, 2% of controls); for individuals without self-reported weight, measured weight was 
used (1% of cases, 2% of controls). The two studies used slightly different approaches to 
assess young-adult weight. In SFBCS, young-adult BMI was based on self-reported weight 
at age 25-30 years for cases diagnosed from 1995-1998 and their matched controls, or on 
self-reported weight at age 20-29 years for cases diagnosed from 1998-2002 and their 
matched controls. In 4-CBCS, young-adult BMI was based on the average of weights 
reported at ages 15 years and 30 years. Weight gain was calculated as the difference 
between self-reported young-adult weight and self-reported weight in the reference year (or 
measured weight at interview if self-reported weight was not available). We calculated 
WHR as a measure of body fat distribution that reflects both adipose tissue (waist 
circumference) and muscle mass (hip circumference), and waist-to-height ratio (WHtR) as a 
measure of visceral adiposity independent of height (18). Current BMI was classified as 
underweight to normal weight (<25.0 kg/m2), overweight (25.0-29.9 kg/m2), or obese 
(≥30.0 kg/m2). All other body size variables were categorized according to the tertile or 
quartile distribution among premenopausal controls. We used the same cut-points for the 
two ethnic groups in order to facilitate the comparison of results. Additionally, we 
performed comparative analyses using ethnic-specific quantiles.
For a subset of study participants with stored DNA (in SFBCS, biospecimen collection 
began with cases diagnosed in April 1997 or later and their matched controls), we estimated 
genetic ancestry using 104 ancestry informative markers (AIMs) (13). Hispanic women 
were classified according to being above or below the median (46%) of Indigenous 
American (IA) ancestry among premenopausal controls.
Statistical Analyses
Unconditional logistic regression was used to calculate odds ratios (OR) and 95% 
confidence intervals (CI) for the associations with body size variables. Polytomous logistic 
regression was used to compare ER+PR+ and ER−PR− case groups to a common control 
group. Other case groups in premenopausal women (97 ER+PR−, 41 ER−PR+) were too 
small for separate analyses. We also stratified the analyses by study (SFBCS, 4-CBCS) to 
evaluate consistency of results.
John et al. Page 4






















Multivariate analyses were adjusted for age (continuous) and study, and additionally, for 
factors significantly associated with risk of ER+PR+ or ER−PR− BC in our dataset. For ER
+PR+ BC, analyses were adjusted for education, BC family history, age at menarche, 
number of full-term pregnancies, age at first full-term pregnancy, lifetime duration of breast-
feeding, oral contraceptive use, and alcohol consumption; for ER−PR− BC, analyses were 
adjusted for alcohol consumption. Analyses in Hispanics additionally adjusted for language 
acculturation. Analyses of overall adiposity measures (current BMI, young-adult BMI, and 
weight gain) were adjusted for waist circumference (adjustment for WHtR produced the 
same results, data not shown), and analyses of abdominal adiposity were adjusted for current 
BMI. Additional adjustment for genetic ancestry did not alter the results (data not shown). 
Variables were categorized as noted in the footnotes of the tables. Linear trends were 
assessed across ordinal values of categorical variables. Significant differences in ORs 
between case groups were tested using the Wald statistic P-value, calculated from the 
polytomous regression model. Two-sided P-values are reported for tests of trend and tests of 
heterogeneity, with P-values <0.05 considered statistically significant.
Analyses in premenopausal women included 1,262 Hispanics (497 cases, 765 controls) and 
1,101 NHWs (448 cases, 653 controls), after excluding individuals with missing data on 
covariates (89 cases, 92 controls) or ER/PR status (241 cases). The analyses by genetic 
ancestry were based on 861 Hispanics (327 cases, 534 controls). Statistical analyses used 
SAS version 9.3 software (SAS Institute, Inc., Cary, NC).
Results
Compared to controls, cases had higher education, younger age at menarche, fewer full-term 
pregnancies, later age at first full-term pregnancy, shorter duration of breast-feeding, and 
were more likely to have a first-degree family history of breast cancer (Table 1). Among 
Hispanics, cases had higher English language acculturation than controls. Compared to 
NHW controls, higher proportions of Hispanic controls were overweight or obese (72% vs. 
45%), had a waist size above the median of 87 cm (59% vs. 38%), and a young-adult BMI 
above the median of 21.7 kg/m2 (63% vs. 35%) (Table 2). Furthermore, Hispanics with 
higher IA ancestry (above the median of 46%) had higher body size measures than those 
with lower IA ancestry.
Body size and ER+PR+ breast cancer
For ER+PR+ BC (Table 3), a suggestive positive trend with height was seen among 
Hispanics overall (Ptrend=0.05), with a stronger association among SFBCS Hispanics (high 
vs. low quartile: OR=1.85, 95% CI=0.94-3.61, Ptrend=0.02; data not shown). Higher young-
adult and current BMI were associated with reduced risk, and adjustment for waist 
circumference strengthened the inverse associations. ORs for high (high vs. low quartile) 
young-adult BMI were similar for Hispanics (OR=0.41, Ptrend <0.01) and NHWs (OR=0.53, 
Ptrend=0.01), and findings were similar in SFBCS and 4-CBCS (data not shown). For current 
obesity (≥30 vs. <25 kg/m2), inverse associations were statistically significant for Hispanics 
(OR=0.48, Ptrend <0.01) and NHWs in SFBCS (data not shown). For weight gain there was 
a suggestive inverse association among Hispanics, but the reduction in risk was statistically 
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significant in SFBCS Hispanics only (high vs. low quartile: OR=0.36, 95% CI=0.18-0.72, 
Ptrend <0.01; data not shown).
Analyses of long-term elevated BMI showed that compared to women with both a lower 
young-adult BMI (<21.8 kg/m2) and current normal-weight BMI (<25 kg/m2), the greatest 
risk reductions of ER+PR+ BC were seen in Hispanics with higher young-adult BMI (≥21.8 
kg/m2) and current overweight (OR=0.39, 95% CI=0.24-0.63) or obesity (OR=0.35, 95% 
CI=0.19-0.62). Similarly, among NHWs, risk was significantly reduced among those with a 
higher young-adult BMI (≥21.8 kg/m2) and current overweight (OR=0.49, 95% 
CI=0.26-0.91).
Among Hispanics, two-fold increased risk of ER+PR+ BC were associated with large waist 
and hip circumferences, and adjustment for current BMI strengthened the associations. For 
WHtR, the trend was of borderline significance (Ptrend=0.06). There were no significant 
associations with WHR. Among NHWs, abdominal obesity was not associated with ER+PR
+ BC, neither overall (Table 3) nor in either study (data not shown);
Body size and ER−PR− breast cancer
For ER−PR− BC (Table 4), significant associations with body size were limited to Hispanic 
women. Height was associated with a two-fold increased risk, whereas young-adult BMI 
was associated with reduced risk, with a stronger inverse association after adjustment for 
abdominal obesity (≥30 vs. <25 kg/m2: OR=0.36, Ptrend <0.01). A significant inverse 
association also was seen for current BMI, when adjusted for abdominal obesity, although 
no significant association remained after additional adjustment for young-adult BMI.
Large waist and hip circumferences and high WHtR were associated with two-fold increased 
risks of ER−PR− BC in Hispanics, with stronger associations after adjustment for current 
BMI. Among NHWs, borderline trends were seen for WHtR (Ptrend=0.07) and WHR 
(Ptrend=0.09).
Joint associations of abdominal and overall obesity with breast cancer risk among 
Hispanics
Since the association with abdominal obesity among Hispanics did not differ significantly 
by ER/PR status, we examined the joint role of overall and abdominal obesity for all BCs 
combined (Table 5). Among overweight Hispanics (BMI 25.0-29.9 kg/m2), BC risk was 
significantly reduced among those with small waist (≤88 cm) or hip (≤106.3 cm) 
circumference or low WHR (≤0.85) or WHtR (≤0.56), but not among those with large waist 
or hip circumference or those with high WHR or WHtR. In contrast, among obese Hispanics 
(BMI ≥30 kg/m2), risk reductions were of similar magnitude, regardless of abdominal 
obesity.
Genetic ancestry, body size and breast cancer risk among Hispanics
In the subset of premenopausal Hispanics with available DNA, there was some variation in 
body size associations by genetic ancestry (Table 6). For ER+PR+ BC, there was a pattern 
of inverse associations with current BMI (Ptrend=0.06 after adjustment for young-adult BMI) 
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and weight gain (Ptrend=0.04) among Hispanics with lower (≤46%) IA ancestry only. 
Similarly, for ER−PR− BC, the inverse association with weight gain was seen in those with 
lower IA ancestry only. Young-adult BMI was inversely associated with ER+PR+ BC 
regardless of IA ancestry, and with ER−PR− BC among Hispanics with higher (>46%) IA 
ancestry only.
For the analyses of abdominal obesity by genetic ancestry, all BCs were combined (Table 
6). Associations of waist circumference (Ptrend=0.01) and WHtR (Ptrend=0.07) were 
somewhat stronger among Hispanics with higher (>46%) IA ancestry.
Discussion
This pooled case-control analysis of over 1,200 premenopausal Hispanic women is the 
largest study to date to evaluate associations between body size and BC risk in U.S. 
Hispanics. Regardless of tumor hormone receptor status, young-adult BMI was inversely 
associated with breast cancer risk, whereas height and waist and hip circumferences were 
associated with increased risk. Current BMI was associated with reduced risk of ER+PR+ 
BC, with the largest reductions in risk found in Hispanics who had an elevated BMI as 
young adults and currently were overweight or obese. Genetic ancestry of Hispanic women 
appeared to modify some of the body size associations. These findings provide evidence that 
overall and abdominal obesity play an important role in BC etiology among premenopausal 
Hispanic women, as has been reported for NHWs, and contribute to the sparse and 
inconsistent epidemiologic data on body size and premenopausal BC risk in Hispanics (6-9).
Adult obesity has been associated with reduced risk of premenopausal BC risk in meta-
analyses of primarily NHW women (3, 19, 20). Similarly in Hispanic women, we found an 
inverse association with current obesity that was independent of young-adult BMI and 
abdominal obesity, although the association was limited to ER+PR+ BC. Furthermore, the 
reductions in risk were highest for women with higher adiposity throughout adulthood, thus 
emphasizing the importance of considering young-adult BMI when examining associations 
with current BMI and weight gain, especially in populations, such as Hispanics, who have a 
higher prevalence of overweight and obesity, even at young ages (12). In our pooled dataset, 
36% of premenopausal Hispanic controls had a young-adult BMI in the highest quartile 
(>24.1 kg/m2) compared to 15% among NHWs. In contrast, for ER−PR− BC, no significant 
inverse associations remained for current BMI after adjustment for young-adult BMI and 
abdominal obesity, suggesting that current obesity may be an important protective factor for 
hormone responsive tumors only. The lower BC risk among obese women has been 
attributed to more frequent anovulatory menstrual cycles and lower estrogen concentrations 
(21), although there is evidence that menstrual cycle characteristics, self-reported infertility, 
and polycystic ovary syndrome do not explain the inverse associations with obesity (22, 23), 
suggesting the importance of other mechanisms yet to be identified.
Consistent with studies in NHW women (24-27), we found strong inverse associations with 
young-adult BMI in Hispanic women, both for ER+PR+ and ER−PR− BC. We previously 
reported inverse associations with adolescent obesity in Hispanics (8, 10) and NHWs (8), 
particularly in premenopausal women with lifelong obesity (10). Inverse associations with 
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childhood or adolescent obesity have also been reported for NHW women (22, 28-31). 
Although the underlying mechanisms remain unclear, these findings suggest that early-life 
adiposity exerts a long-lasting influence on premenopausal BC risk.
In Hispanics, waist and hip circumference and WHtR were strongly associated with 
increased risk of both ER+PR+ and ER−PR− BC. For ER+PR+ BC, however, associations 
emerged only after adjustment for current BMI, whereas for ER−PR− BC, adjustment for 
BMI strengthened the positive associations. Some studies in NHWs have also shown that 
adjustment for BMI strengthened the associations with waist (32, 33), hip (33), or WHR (32, 
34). We found no association with WHR in Hispanics, but a strong association with WHtR, 
an abdominal obesity measure that has previously not been examined in Hispanic women. 
Positive associations with WHR have been reported for NHWs (35, 36), with associations 
limited to ER+PR+ (37) or ER−(38) disease in some studies. In contrast to Hispanics, we 
found no evidence of association with abdominal obesity in NHWs, in agreement with other 
studies (9, 39-42), but unlike a recent meta-analysis that reported a positive association with 
WHR in NHW women (3). The reasons for the differences in abdominal obesity 
associations between Hispanics and NHWs in our pooled analysis are not obvious. 
Abdominal obesity may affect premenopausal BC risk through hormonal, metabolic and 
inflammatory mechanisms (2, 43), and it has been suggested that abdominal adipose tissue 
may be metabolically more active than peripheral adipose tissue (44).
The 4-CBCS, to our knowledge, is the only study that examined possible variations in body 
size associations among Hispanics by genetic ancestry (8). Using a different set of AIMs in 
a population with a more limited range of genetic admixture than the SFBCS, associations 
with BMI and WHR did not differ by genetic ancestry. In contrast, we found that 
associations with adiposity measures were different for Hispanics, depending on the degree 
of genetic admixture: inverse associations of ER+PR+ BC with BMI and weight gain were 
limited to Hispanics with lower IA ancestry, whereas for abdominal obesity, associations 
with BC risk overall were limited to those with higher IA ancestry. These results highlight 
the importance of genetic factors and call for further evaluation.
Our analysis has several strengths, including the population-based design, the large sample 
size, measurements of body size, comprehensive assessment of other BC risk factors by in-
person interview, and availability of information on tumor ER and PR status for most cases. 
The use of measured height for BMI calculation was particularly important, since in the 
SFBCS, 22% of Hispanics did not know their height. Although we measured weight at 
interview, we used self-reported weight during the reference year to calculate BMI because 
of concern about disease- and treatment-related weight gain or loss. In a sensitivity analysis 
limited to women with both measured and self-reported weight and height, we found similar 
associations with BMI based on self-reported or measured height and weight (data not 
shown). Furthermore, the correlation between self-reported and measured weight was high 
both in premenopausal cases (r=0.88) and controls (r=0.91). Some limitations also need to 
be considered. Participation rates differed between the two studies, but the results for 
Hispanic women were generally consistent across the two studies. Although the pooled 
analysis included a large sample of premenopausal Hispanic women and was hypothesis 
driven, the sample size was limited for certain subgroup analyses that considered multiple 
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factors jointly and for analyses of ER−PR− disease. Furthermore, the investigation of 
modifying factors resulted in many comparisons, possibly leading to false-positive results. 
We relied on self-reported young-adult weight and the two studies assessed weight at 
different ages. Data harmonization to estimate average weight in a woman’s twenties may 
not have been optimal and introduced non-differential misclassification, possibly causing the 
associations with weight gain to be attenuated. BMI, a widely used measure of body fat, 
does not distinguish between lean and fat mass (45), or account for differences in body fat 
between individuals with the same BMI or across different racial/ethnic groups (46-48). The 
analyses of abdominal obesity were based on measurements taken after diagnosis which 
may have introduced some misclassification. For example, within 12 months of treatment 
chemotherapy and endocrine therapy have been linked to increases in central fat, regardless 
of changes in body weight (49). Finally, our analyses by genetic ancestry were limited by 
the range of admixture, as only U.S. Hispanics were included.
In conclusion, our findings highlight that body size throughout the premenopausal years has 
a major influence on BC risk and suggest that, in Hispanics, associations with overall and 
abdominal obesity are similar to those previously reported for NHW women, especially 
when considering tumor hormone receptor status. The association between abdominal 
obesity and ER−PR− BC is particularly important since few risk factors have been identified 
for this tumor subtype (50-52), which is more common among Hispanics than NHWs (53). 
Given that obesity and weight gain are associated with increased BC risk after menopause, 
when BC is diagnosed more frequently than at younger ages, avoiding weight gain and 
maintaining a healthy weight are important in both Hispanic and non-Hispanic populations, 
even at a young age, because of the long-term adverse effects of obesity on cancer and other 
chronic disease risk later in life.
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Table 1













 San Francisco Bay Area Breast Cancer Study 430 46 666 47
 4-Corners Breast Cancer Study 515 54 752 53
Estrogen receptor (ER) and
progesterone receptor (PR) status
 ER+PR+ 575 61
 ER+PR− 86 9
 ER−PR+ 37 4




 <40 212 22 342 24
 40-49 564 60 837 59
 50-59 169 18 239 17
Ethnicity/English language acculturation
 Hispanic - low acculturation 54 6 157 11 <0.01
 Hispanic - moderate acculturation 196 21 339 24
 Hispanic - high acculturation 247 26 269 19
 Non-Hispanic White 448 47 653 46
Percent Indigenous American admixture 
4
 ≤46 187 57 267 50 0.07
 >46 140 43 267 50
Education
 Some high school or less 148 16 313 22 <0.01
 High school graduate 192 20 250 18
 Some college or higher 605 64 855 60
Family history of breast cancer
in first-degree relatives
 No 795 84 1278 90 <0.01
 Yes 150 16 140 10
Age at menarche (years)
 <12 222 24 280 20 <0.01
 12-13 497 53 713 50
 ≥14 226 24 425 30
Full-term pregnancies
 Nulliparous 195 21 211 15 <0.01
 1-2 474 50 619 44
 3-4 227 24 469 33


































 ≥5 49 5 119 8
Age at first full-term pregnancy (years)
 Nulliparous 195 21 211 15
 <25 376 40 669 47 <0.01
 25-29 207 22 321 23
 ≥30 167 18 217 15
Lifetime breastfeeding (months)
 Nulliparous 195 21 211 15 <0.01
 0 198 21 238 17
 1-12 294 31 463 33
 13-24 119 13 250 18
 ≥25 139 15 256 18
Oral contraceptive use
 Current 110 12 175 12 0.06
 Former 648 69 886 62
 Never 187 20 357 25
Alcohol consumption (g/day) 
5
 0 473 50 783 55 0.09
 0.1-9.9 314 33 435 31
 10.0-19.9 94 10 121 9
 ≥20.0 64 7 79 6
1
Percentages may not add up to 100% due to rounding.
2
Mantel-Haenszel Chi-square test for difference between cases and controls.
3
Age at diagnosis (cases) or selection into the study (controls).
4
Among Hispanics only; based on the median in premenopausal controls.
5
In the reference year.
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Table 5
Abdominal Adiposity Associations with Premenopausal Breast Cancer in Hispanic 











 (kg/m2) and waist circumference (cm) 
3
 <25.0 / ≤88.0 167 185 1.0
 <25.0 / >88.0 21 20 1.25 0.64-2.45
 25.0-29.9 / ≤88.0 62 159 0.49 0.33-0.71
 25.0-29.9 / >88.0 93 120 0.99 0.68-1.43
 ≥30.0 / ≤88.0 16 29 0.65 0.33-1.28




 (kg/m2) and hip circumference (cm) 
4
 <25.0 / ≤106.3 158 185 1.0
 <25.0 / >106.3 30 21 1.51 0.81-2.81
 25.0-29.9 / ≤106.3 72 159 0.62 0.43-0.90
 25.0-29.9 / >106.3 83 120 0.84 0.58-1.22
 ≥30.0 / ≤106.3 17 29 0.76 0.39-1.49




 (kg/m2) and waist-to-hip ratio 
3
 <25.0 / ≤0.85 162 181 1.0
 <25.0 / >0.85 26 24 1.39 0.75-2.59
 25.0-29.9 / ≤0.85 96 195 0.61 0.43-0.86
 25.0-29.9 / >0.85 59 84 0.98 0.64-1.50
 ≥30.0 / ≤0.85 68 131 0.62 0.42-0.92




 (kg/m2) and waist-to-height ratio 
4
 <25.0 / ≤0.56 176 187 1.0
 <25.0 / >0.56 12 18 0.67 0.31-1.49
 25.0-29.9 / ≤0.56 66 160 0.47 0.32-0.68
 25.0-29.9 / >0.56 89 119 0.95 0.66-1.38
 ≥30.0 / ≤0.56 12 27 0.49 0.23-1.02
 ≥30.0 / >0.56 126 237 0.62 0.44-0.86
Pinteraction = 0.05
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1
Odds ratios and 95% confidence intervals, adjusted for age (years, continuous), study (SFBCS, 4-CBCS), ethnicity/acculturation (low, moderate, 
high, non-Hispanic white), education (less than high school, high school graduate, post high school education), family history of breast cancer in 
first degree relatives (no, yes), age at menarche (<12, 12, 13, ≥14), parity (nulliparous, 1-2, 3-4, ≥5), age at first birth (<20, 20-24, 25-29, ≥30, 
nulliparous), lifetime number of months of breastfeeding (nulliparous, 0, 1-6, 7-12, 13-24, >24), hormonal contraception use (never, former, 
current), average alcohol consumption in reference year (g/day; 0, 0.1-4.9, 5-9.9, 10-19.9, ≥20).
2
Based on self-reported weight in reference year (or measured weight at interview if self-reported weight in reference year was not available) and 
measured height at interview (or self-reported adult height for SFBCS participants for whom measured height was not available).
3
Based on median among all Hispanic premenopausal controls.
4
Based on WHO categories.
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